Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4646.

https://doi.org/10.1182/blood.V128.22.4646.4646

Published: 2016

Journal Articles

Erlotinib Is Not Effective In Patients (Pts) With JAK-2 V617F Positive Polycythemia Vera

Mohamad Cherry, MD, Mohamad Khawandanah, MD, Zhizhuang Joe Zhao, Samer A Srour, MB ChB, Howard Ozer, MD, PhD, George Selby, MD, Bassam Ghabache, MD, Aref Al-Kali, MD

Blood (2013) 122 (21): 1597.

https://doi.org/10.1182/blood.V122.21.1597.1597

Published: 2013

Journal Articles

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Santosh Saraf, MD, Pritesh R. Patel, MB, ChB, Howard Ozer, MD, PhD, David Peace, MD, Sangeetha Nimmagadda, MD, John G. Quigley, MD, Damiano Rondelli, MD

Blood (2011) 118 (21): 4213.

https://doi.org/10.1182/blood.V118.21.4213.4213

Published: 2011

Journal Articles

Patients with Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy with First and Subsequent Cycle Pegfilgrastim Support Experience Low Rates of Neutropenic Complications: Preliminary Results of FIRST, a Prospective Community-Based Study.

Howard Ozer, MD, PhD, Stephen J. Noga, MD, PhD, Vicki A. Morrison, MD, Beiying Ding, PhD, Roger Dansey, MD

Blood (2005) 106 (11): 4705.

https://doi.org/10.1182/blood.V106.11.4705.4705

Published: 2005

Journal Articles

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Kiarash Kojouri, MD, MPH, Christian El-Khoury, MD, Shubham Pant, MD, Nancy Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5204.

https://doi.org/10.1182/blood.V104.11.5204.5204

Published: 2004

Journal Articles

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Christian El-Khoury, MD, Kiarash Kojouri, MD, MPH, Shubham Pant, MD, Nancy Sylvester-Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5206.

https://doi.org/10.1182/blood.V104.11.5206.5206

Published: 2004

NARROW

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Erlotinib Is Not Effective In Patients (Pts) With JAK-2 V617F Positive Polycythemia Vera

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Patients with Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy with First and Subsequent Cycle Pegfilgrastim Support Experience Low Rates of Neutropenic Complications: Preliminary Results of FIRST, a Prospective Community-Based Study.

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Email alerts

ASH Publications

American Society of Hematology

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Erlotinib Is Not Effective In Patients (Pts) With JAK-2 V617F Positive Polycythemia Vera

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Patients with Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy with First and Subsequent Cycle Pegfilgrastim Support Experience Low Rates of Neutropenic Complications: Preliminary Results of FIRST, a Prospective Community-Based Study.

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only